Slide background
Oncology Research and Development

Meü

Slide background
Oncology Research and Development

Meü

Slide background
Oncology Research and Development

Meü

Slide background
Oncology Research and Development

Meü

Projeler

1. Synthesis and Investigation of in vitro Anticancer Properties of Novel 1,4-Naphthoquinone-Thiazole Derivatives and Determination of Their Acid Dissociation Constants, TÜBİTAK, Project Number: 118Z407, 402648 TL, Manager, 2020,Completed.
2. Immunomodulatory and anticancer effects of different carbon nanoparticles and new bacteriophage strains isolated from nature, BAP, Project Number: 2017-2-AP4-2506, 30000 TL, Manager, 2020,Completed.
3. Synthesis of Novel (Bis)Triazole Derivatives, and Investigation of Their Antimicrobial, Antioxidant Properties and Interactions with DNA, TÜBİTAK, Project Number: 119Z033, 43158 TL, Manager, 2020,Completed.
4. , BAP, Project Number: , 11000 TL, Manager, 2018,Completed.
5. Investigation of antioxidant and antimicrobial activity of extracts from Alyssum floribundum Boiss. & Balansa (Brassicaceae) plants, BAP, Project Number: 2017-2-TP2-2531, 11000 TL, Manager, 2018,Completed.
6. An Investigation of the Cytotoxic Effect of Fulvestrant on hERG1 Potassium Channel Gene Expression in MCF-7 Breast Cancer Cell Culture., BAP, Project Number: 2017-2-AP3-2645, 15000 TL, Manager, 2018,Completed.
7. The investigation of Tozasertib, An Aurora Kinase Inhibitor, and Vitamin-D3 on to the CPC (Chromosomal Passanger Complex) Pathway in Leukemic Cells, BAP, Project Number: 2016-1-TP2-1415, 11000 TL, Manager, 2018,Completed.
8. THE INVESTIGATION OF THE EFFECT OF DANUSERTIB, A PAN-AURORA KINASE INHIBITOR, ONTO CYTOTOXICITY, CELL CYCLE AND APOPTOSIS IN PANCREATIC CANCER CELLS , BAP, Project Number: 2017-1-TP2-2252, 10996 EUR, Manager, 2018,Completed.
9. THE INVESTIGATION OF THE EFFECT OF DANUSERTIB, A PAN-AURORA KINASE INHIBITOR, ONTO AUTOPHAGY, METASTASİS AND EPİTHELİAL MESENCHYMAL TRANSİTİON (EMT) IN PANCREATIC CANCER CELLS, BAP, Project Number: 2017-1-TP2-2254, 10995 EUR, Manager, 2018,Completed.
10. investigation of the Biological Effect of Extracts Obtained from Onosma mutabilis boiss. (Boraginaceae) Plant on the DU145 Prostate Cancer Cell Line , BAP, Project Number: 2017-1-TP2-2265, 6902 TL, Manager, 2018,Completed.
11. In Vitro Investigation of Anticancer Effects of Arum dioscoridis Plant Extracts with the Tozasertib onto the CFPAC-1 Pancreatic Carcinoma Cell Line, BAP, Project Number: 2016-1-TP3-1414, 20900 TL, Manager, 2017,Completed.
12. Aurora Kinaz B İnhibitörü Tozasertib ve Metilprednizolon birlikteliğinin lösemik hücrelerde CPC (Chromosomal Passanger Complex) Yolağı Üzerindeki Etkilerinin Araştırılması, BAP, Project Number: 2015-TP2-1177, 7000 TL, Manager, 2017,Completed.
13. İncidence of euthyroid sick syndrome in pediatric oncology departments childs, BAP, Project Number: 2016-1-TP3-1432, 5000 TL, Manager, 2017,Completed.
14. The investigation of the effect of tozasertibe, a Aurora Kinase-B inhibitor, onto the Chromosomal Passanger Complex (CPC) pathway in Pancreatic Carcinoma Cells., BAP, Project Number: MEÜ BAP-FBE BB(HÇ) 2014-1YL, 10000 TL, Manager, 2015,Completed.
15. The investigation of effect of Fasudil (HA-1077), a Rho kinase inhibitor, onto the relation of cytotoxicity, apoptosis and metastasis in pankreatic carcinoma cells (BxPC-3), BAP, Project Number: MEÜ-BAP-FBE BB (CK) 2012-4 YL, 10000 TL, Manager, 2015,Completed.
16. The investigation of gene expressions of Supressor of the Cytokine Signalling in methylprednisolone and vitamin-D3 treatment chronic myeloblastic leukemia (K-562) cells, BAP, Project Number: MEÜ-BAP BB(BM) 2009-7 YL , 7000 TL, Manager, 2011,Completed.
17. The synergistic effect of Metilprednizolon and Vitamine-D3 onto the DR-nm23 gene expression, apoptosis and differentiation in leukemic cells, BAP, Project Number: ”. MEÜ-BAP FEF(AAÖ) 2007-1, 10000 TL, Manager, 2008,Completed.
18. The investigation of the expression levels of miRNA processing genes DICER, DROSHA, XPO5, DGCR8, TARP2, AGO1 ve AGO2 in hematologic malignancies, BAP, Project Number: 2015-TP3-1205, 18000 TL, Researcher, 2018,Completed.
19. İnvestigation of sox-2 and B-katenin expression for diagnosis in adenoma-carcinoma sequence of colon polyps, BAP, Project Number: 2015-TP3-1254, 14332 TL, Researcher, 2016,Completed.
20. The investigation of Doxorubicin’s anti-cancer effects on pancreas carcionoma (BxPC-3) cell line, BAP, Project Number: MEÜ BAP-FBE BB(TY) 2013-4 YL, 10000 TL, Researcher, 2014,Completed.
21. The determination of DR-nm23 gene expression level in Acute Myeloid Leukemia patients treatment with high dose methylprednisolone (HDMP), HUBAP, Project Number: HÜ-BAP 01 02 101 022, 28000 TL, Researcher, 2008,Completed.
22. Rho Kinaz ve Siklooksijenaz İnhibitörleri ile Siklofosfamid Kombinasyonlarının Çeşitli Tümör Hücre Serilerine Etkileri, BAP, Project Number: TF-TTB-NAA-2006-1, 30000 TL, Researcher, 2008,Completed.
23. The investigation of the effect of Acetylsalicilic acide (aspirine) and Rho-kinase Y-27632 combinations onto the human neuroblastoma and leukemia cell line, BAP, Project Number: MEÜ-BAP TF TTB (NAA) 2006-1, 40000 TL, Researcher, 2007,Completed.
24. The effects of Rho-kinase and cyclooxigenase inhibitors with cyclophosphamide combinations onto the range of tumor cell lines, BAP, Project Number: MEÜ-BAP SBE TTB (ED) 2006-1 DR, 5000 TL, Researcher, 2007,Completed.
25. The effect of steroid on DR-nm23 gene expression, apoptosis and differentiation in human acute myeloid leukemia (HL-60) cell line, TÜBİTAK, Project Number: TÜBİTAK SBAG- 2515 (101S215), 10000 TL, Researcher, 2005,Completed.